Interview: Kevin Moodaley – Head of Operations, Hetero Drugs South Africa
12.08.2015
Related Interviews
Interview: Charl De Klerk – General Manager, Bard South Africa
The general manager of Bard SA, Charl De Klerk, illustrates the company’s growth ambitions within South Africa and Sub-Saharan Africa, while also depicting how Bard has adapted its therapeutic portfolio…
Interview: Albert Denoon – Owner, Baroque Medical, – Board Member,…
Albert Denoon (AB) and Jeff Hampton (JH) illustrate how the Crossroads and Campbell Institutes, two non-profit organizations funded by Baroque Medical, are well positioned to address South Africa’s current gaps…
Interview: Andre Buhrlen – Managing Director, Hersol Manufacturing…
Hersol prides itself on producing high-quality products and is today one of the leading Pharmaceutical Contract Manufacturing Companies (CMOs) within the South African Market. The managing director discusses the development…
HIV / Janssen’s Johan Van Hoof on Search for The Vaccine ‘Holy Grail’
With several COVID-19 vaccines gaining regulatory approval across the world in record time, a spotlight has been shone on the vaccines field more widely, notably the 30-year wait for a…
In Profile / Stéphane De Wit, A Pioneer in HIV Research
Belgian doctor, researcher and professor, Stéphane De Wit has been with the St Pierre University Hospital in Brussels since 1983. Initially planning to specialize in intensive care, his first internship…
COVID-19 Vaccine / Lessons from the History of HIV
Against the backdrop of an unprecedented collaborative global push to develop a COVID-19 vaccine, pharma industry executives and patient advocacy representatives at the BIO 2020 digital conference discussed the progress…
Latest Report
